Work

Management of common adverse events related to first-line dacomitinib use in EGFR mutation-positive non-small-cell lung cancer: a pooled safety analysis

Year: 2019

Type: article

Source: Future Oncology

DOI: 10.2217/fon-2018-0944

Authors: Qing Zhou, Yi-Long Wu, Jesus Corral, Kazuhiko Nakagawa, Edward B Garon, Eric I Sbar, Tao Wang, Rickard Sandin, Kay Noonan, Diana Gernhardt, Tony S Mok

Institutions: Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Clinica Universidad de Navarra, Kindai University Hospital, University of California, Los Angeles, Pfizer (United States), Pfizer (Sweden), Chinese University of Hong Kong

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2921027277

FWCI: 1.647

Cites: 19

Cited by: 15

Related to: 10